Clinical trials show progress in migraine frequency, skin cancer prevention
-
1:39
Man killed, 2 others injured in early morning shooting near Brady...
-
1:06
St. Camillus residents show patriotic spirit during annual parade
-
1:22
Greenfield residents urged to monitor mail after thefts continue...
-
1:58
ICE detains 8-year-old boy and mom at Wisconsin Dells home, community...
-
1:55
‘Bucks basketball won’t be the same’: Bucks fans say goodbye...
-
0:39
3-alarm fire damages vacant Milwaukee warehouse
-
8:46
Milwaukee mayor reflects on Giannis, Portis impact beyond basketball...
-
3:34
Financial expert shares emergency fund tips as credit card debt...
-
2:23
Staying cool the rest of the week before a big warm-up to end...
-
2:22
Meet CBS 58’s Pet of the Week: Ramsey
-
3:14
Natalie’s Everyday Heroes: Artists head outdoors for ’Plein...
-
1:45
Wisconsin governor candidates field rapid-fire questions at Pewaukee...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.